FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088695411> ?p ?o ?g. }

• W3088695411 endingPage "325" @default.
• W3088695411 startingPage "320" @default.
• W3088695411 abstract "A major evolution in the treatment of patients with diffuse large B-cell lymphoma (DLBCL) occurred almost two decades ago, with clinical trials demonstrating that the addition of rituximab (R) to cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP), which had been the “gold standard” of therapy since 1976, significantly improved outcome, including response rate and disease-free survival, of these patients. Since the adoption of R-CHOP, subsequent clinical trials have attempted to improve upon outcomes achieved with R-CHOP, with a variety of approaches examined. These have included dose intensification, which may be applicable in younger patients, but not in the many older or frailer patients with a disease with median age at diagnosis in the 60's. Newer anti-CD20 monoclonal antibodies have been substituted for rituximab in frontline regimens. A series of new agents, with unique mechanisms of action, have been added to the R-CHOP backbone. Rituximab-based, non-anthracycline regimens have been studied for older, more frail patients. The utility of maintenance therapy in responding patients has been re-examined, despite the lack of benefit found in the US Intergroup trial. Advances in molecular and genetic aspects of DLBCL have emerged since the seminal R-CHOP trials, demonstrating the DLBCL is not a single entity, but instead a spectrum of multiple disease subtypes. Attempts have been made to identify those patients at baseline who have poorer outcomes with standard approaches, utilizing laboratory and imaging findings. Moving forward, different risk-adapted treatment approaches will be studied to in an effort to improve overall outcome beyond R-CHOP." @default.
• W3088695411 created "2020-10-01" @default.
• W3088695411 creator A5022885582 @default.
• W3088695411 date "2021-03-01" @default.
• W3088695411 modified "2023-09-26" @default.
• W3088695411 title "Frontline therapy with R-CHOP for diffuse large B-cell lymphoma: Where have we come (or not come)? A Perspective" @default.
• W3088695411 cites W1143070445 @default.
• W3088695411 cites W1811564540 @default.
• W3088695411 cites W1946250925 @default.
• W3088695411 cites W2024972915 @default.
• W3088695411 cites W2028850684 @default.
• W3088695411 cites W2032685816 @default.
• W3088695411 cites W2049141040 @default.
• W3088695411 cites W2056641238 @default.
• W3088695411 cites W2057221507 @default.
• W3088695411 cites W2058015212 @default.
• W3088695411 cites W2087824134 @default.
• W3088695411 cites W2098488028 @default.
• W3088695411 cites W2106928992 @default.
• W3088695411 cites W2110372244 @default.
• W3088695411 cites W2125523937 @default.
• W3088695411 cites W2126779872 @default.
• W3088695411 cites W2127081633 @default.
• W3088695411 cites W2127552847 @default.
• W3088695411 cites W2131424155 @default.
• W3088695411 cites W2135860817 @default.
• W3088695411 cites W2136268782 @default.
• W3088695411 cites W2139836848 @default.
• W3088695411 cites W2153665789 @default.
• W3088695411 cites W2158267770 @default.
• W3088695411 cites W2166900358 @default.
• W3088695411 cites W2171356556 @default.
• W3088695411 cites W2310716991 @default.
• W3088695411 cites W2339030197 @default.
• W3088695411 cites W2404692795 @default.
• W3088695411 cites W2414395973 @default.
• W3088695411 cites W2487308472 @default.
• W3088695411 cites W2522108802 @default.
• W3088695411 cites W2534379449 @default.
• W3088695411 cites W2559431510 @default.
• W3088695411 cites W2563063147 @default.
• W3088695411 cites W2567574870 @default.
• W3088695411 cites W2605767476 @default.
• W3088695411 cites W2742627598 @default.
• W3088695411 cites W2751075585 @default.
• W3088695411 cites W2763493665 @default.
• W3088695411 cites W2771658548 @default.
• W3088695411 cites W2799900329 @default.
• W3088695411 cites W2895729920 @default.
• W3088695411 cites W2902375153 @default.
• W3088695411 cites W2923453543 @default.
• W3088695411 cites W2927138762 @default.
• W3088695411 cites W2961408778 @default.
• W3088695411 cites W3002263815 @default.
• W3088695411 cites W3011375925 @default.
• W3088695411 cites W3013950250 @default.
• W3088695411 cites W2883139639 @default.
• W3088695411 doi "https://doi.org/10.1016/j.jgo.2020.09.015" @default.
• W3088695411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32972884" @default.
• W3088695411 hasPublicationYear "2021" @default.
• W3088695411 type Work @default.
• W3088695411 sameAs 3088695411 @default.
• W3088695411 citedByCount "1" @default.
• W3088695411 countsByYear W30886954112023 @default.
• W3088695411 crossrefType "journal-article" @default.
• W3088695411 hasAuthorship W3088695411A5022885582 @default.
• W3088695411 hasConcept C121608353 @default.
• W3088695411 hasConcept C126322002 @default.
• W3088695411 hasConcept C143998085 @default.
• W3088695411 hasConcept C2776694085 @default.
• W3088695411 hasConcept C2776755627 @default.
• W3088695411 hasConcept C2776802502 @default.
• W3088695411 hasConcept C2778559949 @default.
• W3088695411 hasConcept C2778720950 @default.
• W3088695411 hasConcept C2779338263 @default.
• W3088695411 hasConcept C2779429289 @default.
• W3088695411 hasConcept C2779725641 @default.
• W3088695411 hasConcept C2780653079 @default.
• W3088695411 hasConcept C530470458 @default.
• W3088695411 hasConcept C535046627 @default.
• W3088695411 hasConcept C71924100 @default.
• W3088695411 hasConceptScore W3088695411C121608353 @default.
• W3088695411 hasConceptScore W3088695411C126322002 @default.
• W3088695411 hasConceptScore W3088695411C143998085 @default.
• W3088695411 hasConceptScore W3088695411C2776694085 @default.
• W3088695411 hasConceptScore W3088695411C2776755627 @default.
• W3088695411 hasConceptScore W3088695411C2776802502 @default.
• W3088695411 hasConceptScore W3088695411C2778559949 @default.
• W3088695411 hasConceptScore W3088695411C2778720950 @default.
• W3088695411 hasConceptScore W3088695411C2779338263 @default.
• W3088695411 hasConceptScore W3088695411C2779429289 @default.
• W3088695411 hasConceptScore W3088695411C2779725641 @default.
• W3088695411 hasConceptScore W3088695411C2780653079 @default.
• W3088695411 hasConceptScore W3088695411C530470458 @default.
• W3088695411 hasConceptScore W3088695411C535046627 @default.
• W3088695411 hasConceptScore W3088695411C71924100 @default.
• W3088695411 hasIssue "2" @default.
• W3088695411 hasLocation W30886954111 @default.

• next